CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

In This Article:

  • FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEAR

  • FOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR

  • FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% 

  • FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR

  • FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY

  • DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION

  • COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER

  • COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND

  • FULL YEAR REVENUE OF $523.8 MILLION, UP 3%

  • FULL YEAR OPERATING INCOME OF $58.6 MILLION; EX-ITEMS, $65.3 MILLION, UP 7%

  • FULL YEAR GAAP EPS OF $0.66; EX-ITEMS, EPS OF $0.87, UP 9%

  • FULL YEAR FREE CASH FLOW OF $43.4 MILLION, UP OVER 200% COMPARED TO 2023

HOUSTON, Jan. 29, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported fourth quarter 2024 revenue of $129,200,000. Core's operating income was $14,200,000, with diluted earnings per share ("EPS") of $0.15, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $15,700,000, yielding operating margins of 12%, and EPS, ex-items, of $0.22. For the full year 2024, revenue of $523,800,000 was up 3% compared to 2023, generating operating income, ex-items, of $65,300,000 with incremental margins of 29%. The Company's full year EPS, ex-items, was $0.87, representing year-over-year growth of 9%. A full reconciliation of non-GAAP financial measures is included in the attached financial tables.

Core Laboratories logo (PRNewsFoto/Core Laboratories) (PRNewsfoto/Core Laboratories)
Core Laboratories logo (PRNewsFoto/Core Laboratories) (PRNewsfoto/Core Laboratories)

Core's CEO, Larry Bruno stated, "Our full year financial results delivered improvements in revenue, operating income, operating margins, free cash flow and earnings per share. Our performance was driven by resilient demand for our Reservoir Description services which continued to grow across our international laboratory network despite headwinds from reduced U.S. land activity and disruptions caused by on-going geopolitical conflicts and associated sanctions. Core's investments to expand capabilities in the Middle East are now yielding returns. While Production Enhancement experienced higher international product sales and increased demand for Core's completion diagnostic services, full year financial performance was adversely impacted by lower levels of onshore well completions in the U.S. compared to 2023. The Company also continued to strengthen its balance sheet by reducing debt. As of December 31, 2024, our debt leverage ratio was reduced to 1.31, the lowest it has been in over eight years. Core remains focused on executing its strategic business priorities which include further reduction of debt and strengthening the balance sheet. In addition, we will remain active in pursuit of growth opportunities and maintain our long-standing practice of returning excess free cash to our shareholders, as we did in the fourth quarter through a combination of share buybacks and our quarterly dividend."